RxDoctor Payments Data

Troy Espiritu

Podiatrist · Columbus, GANPI 1780775791

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,251 of the $5,752 with a category attached, or 73.9%. 35 manufacturers reported payments, led by Organogenesis Inc. at 27.8% of the total. Reporting peaked in 2023 at $2,099 and has fallen 79.3% since, to $434 in 2025.

$5,752in general payments, 2019–2025

Across 216 payments — averaging $26.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$2K
  • CGG Medical Inc$1K
  • Amgen$789
  • Arthrex$621
  • Smith+Nephew$262
  • Pfizer$147
  • plus $1K from 29 others

What the payments were for

  • Travel & lodging$1,45325%
  • Food & beverage$4,25174%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,752 in reported general payments places this provider in the 75th percentile of 177 podiatrist providers in Georgia.

See all podiatrist providers in Georgia

Medicare billing

Part B allowed, 2024
$317,516
Medicare patients
814
Services billed
3,529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin52$4,660
Ciclopirox103$3,046
CiclopiroxCiclopirox Olamine50$1,891
Gabapentin108$1,804
Terbinafine Hcl57$1,052
Mupirocin144$872
Diclofenac Sodium37$800
Celecoxib43$684
Ammonium Lactate38$611
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen60$451
Meloxicam109$384
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$276
Colchicine14$272
Levofloxacin38$164
Cephalexin49$155

Paid to pharmacies, not to this prescriber.

Other podiatrist in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →